Clinical trialNCT01826201CompletedPhase 2Interventional

Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis

SponsorMoleculin, LLCEnrollment21Psoriasis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether MOL4239 is effective in adult subjects with mild to moderate plaque psoriasis by comparing two target lesions in which each subject will apply MOL4239 ointment to one target lesion and placebo ointment to the contralateral target lesion twice a day for 28.5 consecutive days.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Eduardo Tschen, MD
Academic Dermatology Associates
Principal Investigator
clinicaltrials.gov ↗
Javier Alonso-Llamazares, MD
International Dermatology Research, Inc.
Principal Investigator
clinicaltrials.gov ↗
Steven Kempers, MD
Minnesota Clinical Study Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

International Dermatology Research, Inc.
Miami, Florida, United States
Minnesota Clinical Study Center
Fridley, Minnesota, United States
Academic Dermatology Associates
Albuquerque, New Mexico, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MOL4239Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2013
Primary completion: 31 Aug 2013
Completion: 31 Aug 2013
Last update posted: 24 Dec 2014
Registered enrollment: 21
Registry id: NCT01826201

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.